Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Adding a second method to PROTACs could improve cancer treatment.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Stimulating sensory neurons can increase IGF-I production, which may help treat various diseases and improve tissue health.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

AH-001 could be a safer and more effective treatment for hair loss.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.